DEBIRI (irinotecan-eluting bead)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for DEBIRI (irinotecan-eluting bead), covering 2017-06-27 to 2017-06-27. Get the full timeline:
Most recent: Clinical Trial Update: Irinotecan-Eluting Bead (DEBIRI) for Patients With Liver Metastases From Colorectal Cancer [Phase 2, Phase 3]